Patients Coming Off Weight-Loss Injections Regain Pounds at a Quadrupled Rate Than People Using Diet and Exercise

Fresh analysis indicates that people who come off new slimming jabs like semaglutide or tirzepatide may regain reduced body mass far faster than those who halt traditional diet and exercise programs.

Published data in a leading health publication points out that while obese people frequently drop substantial amounts of their total mass while on the medication, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Users using these drugs need to be aware of the danger of quick weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.

This pace of recovery suggests a return to starting mass within about a year and a half.

Weighing Approaches

The analysis, which looked at dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with conventional dieting.

The team point out that individuals who shed pounds through diet and exercise typically experience a slower weight regain—around 100 grams monthly—post-intervention.

The Reason for the Quick Regain

Nutrition scientists believe the mode of action of the jabs accounts for the accelerated regain.

These medications copy a body's own chemical called GLP-1, which controls hunger.

"Long-term administration of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication means appetite is no longer kept in check, making overeating far more likely."

A Chronic Issue?

Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

Professionals argue that, considering the likelihood of weight regain, the treatment should be considered life-long.

This opinion is echoed by pharmaceutical companies, who say that the results "emphasize the long-term character of obesity," akin to managing conditions like hypertension.

User Testimonies

People who have discontinued the medication describe a powerful return of cravings.

"It was like a trigger flipping and you become ravenous," said one woman.

This challenge is exacerbated if individuals have not adopted lasting lifestyle or habit modifications during therapy.

Significant Use

Survey data suggest that millions of adults in the UK have used these injections in the last 12 months, with desire being substantial.

• Use is greater among females compared to men.
• The middle-aged demographic shows the greatest level of interest.
• Many access the drugs through private prescriptions rather than the NHS.

In conclusion, clinicians caution that while the jabs are potent tools for weight loss, they are not a permanent solution and maintained weight loss likely depends on combined lifestyle changes.